Increasing The Reach: Optimizing Screening For Atrial Fibrillation: The STROKESTOP III Study.
Mashroor KhanMichael IngreFredrik CarlstedtAnders ErikssonSofia SkröderJohanna Star TennMårten RosenqvistEmma SvennbergPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2024)
In our study, STROKESTOP III, a randomized prospective cohort study, we compare two different methods of AF screening in high-risk individuals: population screening vs. opportunistic screening. Sixteen different primary clinics in Värmland, Sweden, serving 75-76-year-old individuals (n = 2954), will be randomized to either population screening or opportunistic screening. The individuals will be instructed to record ECG for 30 seconds, 3 times daily for two weeks, using a handheld one-lead ECG device. Patients with detected AF will be referred to their primary healthcare physician and offered treatment. The main objective of the study is to determine the rate of participation in opportunistic screening in comparison to population screening.
Keyphrases